A bridge too far: Cape Town lacks funds to finish iconic landmark on the Foreshore
The City of Cape Town says it lacks funds to complete the iconic unfinished Foreshore freeway bridge in the CBD.
This was revealed during a public meeting on the draft Cape Town CBD Local Spatial Development Framework Plan.
The City said a feasibility study is under way but added budget funding for the bridge was unviable.
The City of Cape Town says it does not have funds to finish the iconic Foreshore bridge.
This emerged during a public meeting on Wednesday afternoon for a draft of the Cape Town CBD Local Spatial Development Framework Plan (LSDF).
The draft of the City's LSDF aims to guide future spatial planning and development of the CBD - one of Cape Town's busiest economic hubs.
It proposes development guidelines for eight demarcated precincts: De Waterkant, the convention district, mid-city, Company's Garden, East Foreshore, District Six, Cape Town station and Lower Gardens.
While the City confirmed a feasibility study was under way for the freeway bridge, it said its budget funding for such a project was not viable.
The unfinished bridge has become a popular location for movies and advertisements and a home for people experiencing homelessness.
Its design started in the 1960s, and construction began in the 1970s, but due to budget constraints, it halted in 1977.
During the meeting, Annelise de Bruin from Spatial Planning and Urban Growth Management at the City said: 'The feasibility study is an in-house project to figure out what do we do with the freeways and what do you do with the land under the Foreshore freeway.'
According to the LSDF plan, the scope of the feasibility study will focus on urban design concept, linkages, financing and public participation.
'The Foreshore internal work will be completed around June this year, and from there on, the city manager will decide to what extent he goes into a public consultation period, and if that is complete, there will be further discussions about the legal statutory processes,' De Bruin said.
'At the moment, we do not have a definitive answer on the feasibility or even if it's feasible for the City to complete the bridge or what we should do with the freeways because the City does not have this kind of money to complete the freeways, but we have to think of long-term mobility in the context of the vision of the CBD,' she added.
The City's urban designer and professional architect, Anees Arnold, said: 'The LSDF is supposed to provide certainty to developers or those who want to develop in the city potentially … and how certain areas respond to the broader context and the character area where it sits.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Lifezone Metals Publishes its 2024 Sustainability Report
Committed to Responsible Mining Practices and Advancing Cleaner Hydromet Technology NEW YORK, June 20, 2025--(BUSINESS WIRE)--Lifezone Metals Limited's (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Head of Sustainability, Catherine Nichas, announce today the publication of Lifezone's Sustainability Report for the year ended December 31, 2024. Lifezone is the operator of the Kabanga Nickel Project in Tanzania and is advancing cleaner battery metals production through the application of its Hydromet Technology. The report outlines Lifezone's comprehensive approach to environmental stewardship, social responsibility, safety and governance (ESG), and highlights the Company's progress in embedding sustainability across its global operations. Highlights: Environmental Progress: Meaningful progress on uplifting the Environmental and Social Impact Assessments to international standards; transitioned the Kabanga Nickel Project to grid power, reducing diesel consumption by over 75%; initiated land rehabilitation and biodiversity restoration programs. Social Impact: Completed 96% of cash compensation payments, totaling $10.5 million, to Project Affected Households; recorded over 2.2 million hours worked without lost time injury at the Kabanga Site; conducted over 430 stakeholder engagements in Tanzania and continued with ongoing Corporate Social Responsibility initiatives focused on local education and healthcare initiatives. Governance and Transparency: Continued integrating sustainability oversight at the Board level; aligned internal reporting with Sustainability Accounting Standards Board standards; progressed towards being International Finance Corporation aligned; completed first Human Rights Due Diligence assessment and initiated Life Cycle Assessments for key projects. Mr. Showalter commented: "This report marks an important milestone for Lifezone. It reflects our commitment to transparency, responsible growth, and delivering long-term value to our stakeholders – while minimizing our environmental footprint and maximizing our positive social impact. We are especially proud of the 2.2 million hours worked without a lost time injury at Kabanga – a testament to our culture of safety and operational excellence." Ms. Nichas added: "Sustainability is not a side initiative – it is central to how we operate. This report provides a strong foundation for future disclosures as we continue to scale our operations and deliver meaningful, measurable outcomes for our stakeholders." The full 2024 Sustainability Report is available on Lifezone's website. If you would like to sign up for Lifezone Metals news alerts, please register here. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is committed to delivering cleaner and more responsible metals production and recycling. Through the application of our Hydromet Technology, we offer the potential for lower energy consumption, lower emissions and lower cost metals production compared to traditional smelting. Our Kabanga Nickel Project in Tanzania is believed to be one of the world's largest and highest-grade undeveloped nickel sulfide deposits. By pairing it with our Hydromet Technology, we are working to unlock a new source of nickel, copper and cobalt for the global battery metals markets and to empower Tanzania to achieve in-country beneficiation. Through our US-based recycling partnership, we are working towards applying our Hydromet Technology to the recovery of platinum, palladium and rhodium from responsibly sourced spent automotive catalytic converters. Our process is expected to be cleaner and more efficient than conventional smelting and refining methods, supporting a circular economy for precious metals. Forward-Looking Statements Certain statements made herein are not historical facts but may be considered "forward-looking statements" within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 regarding, amongst other things, the plans, strategies, intentions and prospects, both business and financial, of Lifezone Metals Limited and its subsidiaries. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, and any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements may be accompanied by words such as "believes," "estimates," "expects," "predicts," "projects," "forecasts," "may," "might," "will," "could," "should," "would," "seeks," "plans," "scheduled," "possible," "continue," "potential," "anticipates" or "intends" "or the negatives of these terms or variations of them or similar terminology or expressions that predict or indicate future events or trends or that are not statements of historical matters; provided that the absence of these does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding future events, the estimated or anticipated future results of Lifezone Metals, future opportunities for Lifezone Metals, including the efficacy of Lifezone Metals' hydrometallurgical technology (Hydromet Technology) and the development of, and processing of mineral resources at, the Kabanga Nickel Project, our approach to environmental stewardship, social responsibility, safety and governance (ESG), and other statements that are not historical facts. These statements are based on the current expectations of Lifezone Metals' management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Lifezone Metals and its subsidiaries. These statements are subject to a number of risks and uncertainties regarding Lifezone Metals' business, and actual results may differ materially. These risks and uncertainties include, but are not limited to: general economic, political and business conditions, including but not limited to economic and operational disruptions; global inflation and cost increases for materials and services; capital and operating costs varying significantly from estimates; delays in obtaining or failures to obtain required governmental, environmental or other project approvals; changes in government regulations, legislation and rates of taxation; inflation; changes in exchange rates and the availability of foreign exchange; fluctuations in commodity prices; delays in the development of projects and other factors; the outcome of any legal proceedings that may be instituted against Lifezone Metals; our ability to obtain additional capital, including use of the debt market, future capital requirements and sources and uses of cash; the risks related to the rollout of Lifezone Metals' business, the efficacy of the Hydromet Technology, and the timing of expected business milestones; the acquisition of, maintenance of and protection of intellectual property; Lifezone's ability to achieve projections and anticipate uncertainties (including economic or geopolitical uncertainties) relating to our business, operations and financial performance, including: expectations with respect to financial and business performance, future operating results, financial projections and business metrics and any underlying assumptions; expectations regarding product and technology development and pipeline and market size; events relating to environmental issues, social responsibility, safety and/or governance matters, expectations regarding product and technology development and pipeline; future acquisitions, partnerships, or other relationships with third parties; maintaining key strategic relationships with partners and customers; the timing and significance of contractual relationships; the effects of competition on Lifezone Metals' business; the ability of Lifezone Metals to execute its growth strategy, the development and processing of the mineral resources at the Kabanga Nickel Project;; manage growth profitably and retain its key employees; the ability of Lifezone Metals to reach and maintain profitability; enhancing future operating and financial results; complying with laws and regulations applicable to Lifezone Metals' business; Lifezone Metals' ability to continue to comply with applicable listing standards of the NYSE; the ability of Lifezone Metals to maintain the listing of its securities on a U.S. national securities exchange; our ability to comply with applicable laws and regulations; stay abreast of accounting standards, or modified or new laws and regulations applying to our business, including privacy regulation; and other risks that will be detailed from time to time in filings with the U.S. Securities and Exchange Commission (SEC) meeting future liquidity requirements and complying with restrictive covenants related to long-term indebtedness; and dealing effectively with litigation, complaints, and/or adverse publicity.. The foregoing list of risk factors is not exhaustive. There may be additional risks that Lifezone Metals presently does not know or that Lifezone Metals currently believes are immaterial that could also cause actual results to differ from those contained in forward-looking statements. In addition, forward-looking statements provide Lifezone Metals' expectations, plans or forecasts of future events and views as of the date of this communication. Lifezone Metals anticipates that subsequent events and developments will cause Lifezone Metals' assessments to change. These forward-looking statements should not be relied upon as representing Lifezone Metals' assessments as of any date subsequent to the date of this communication. You should not place undue reliance on forward-looking statements in this communication, which are based upon information available to us as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. In all cases where historical performance is presented, please note that past performance is not a credible indicator of future results. Except as otherwise required by applicable law, we disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data, or methods, future events, or other changes after the date of this communication. View source version on Contacts Sustainability Catherine NichasHead of Investor Relations – North America Evan YoungSVP: Investor Relations & Capital Investor Relations – Europe Ingo HofmaierChief Financial 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Bloomberg
an hour ago
- Bloomberg
South African Stocks Tipped to End Decade of Foreign Outflows
The valuation discount of South African equities relative to developing peers is set to narrow as some of the capital flowing out of the US and into emerging markets finds its way to Johannesburg stocks, according to Momentum Investments. Foreign investors have been net sellers of South African stocks every year since 2016, and net outflows year-to-date already amount to $6.3 billion, according to JSE Ltd. data. Even so, the benchmark FTSE/JSE Africa All Share Index is outperforming the MSCI Emerging Market stock index and the S&P 500 in dollar terms this year.
Associated Press
2 hours ago
- Associated Press
mRNA Technology Transfer Programme's Phase 2.0 discussed with partners on the sidelines of G20 Summit
With the G20 Health Working Group, global health leaders are coming together to set the foundation for a new phase of the mRNA Technology Transfer Programme 'This is a unique opportunity, driven by the pandemic. The foundations are in place — but without sustained political will, the promise of equitable mRNA access could slip through our fingers.'— Charles Gore, Executive Director of the Medicines Patent Pool JOHANNESBURG, GAUTENG, SOUTH AFRICA, June 20, 2025 / / -- In parallel with the G20 Health Working Group, global health leaders are coming together in Johannesburg to set the foundation for a new phase of the mRNA Technology Transfer Programme – a pioneering initiative transitioning from proof of concept to sustainable, commercially viable manufacturing, while enhancing pandemic preparedness and regional health security. Launched in 2021 by the World Health Organization (WHO) and the Medicines Patent Pool (MPP), with the support of the Government of South Africa, France, Belgium, Canada, the European Union, Germany and Norway, the Programme has successfully enabled 15 Partners across Latin America, Africa, Eastern Europe and Asia to receive foundational mRNA technology. Now, it is moving into Phase 2.0 (2026–2030), with the aim of empowering regional manufacturers to scale up commercially sustainable production of mRNA-based vaccines and therapeutics at Good Manufacturing Practices (GMP)-grade. 'The mRNA Technology Transfer Programme is delivering on its promise to build capabilities in low- and middle-income countries,' said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. 'The Pandemic Agreement adopted by the World Health Assembly also includes legally-binding commitments to strengthen local production. We must now translate those commitments into capacity on the ground, so that when the next pandemic strikes, we meet it more equitably and more effectively.' 'This is a unique opportunity, driven by the pandemic. The foundations are in place — but without sustained political will, the promise of equitable mRNA access could slip through our fingers.' said Charles Gore, Executive Director of the Medicines Patent Pool. 'What we need now is the courage to build on our investment to date, to align, and to realise the full value and impact of what we started.' From technology access to market-ready solutions The Programme is moving from focus on technology acquisition to defining how each partner will translate it into real-world impact. Each manufacturer is now focused on developing an economic case for long-term, flexible, and commercially viable manufacturing — with the capacity to produce mRNA vaccines in inter-pandemic periods and pivoting rapidly in response to future health emergencies. Product focus areas include: mRNA vaccines – for pandemic and priority diseases (e.g., influenza, TB, HIV, malaria, dengue, leishmaniasis); mRNA therapeutics – such as oncology and monoclonal antibody (mAb) treatments; and Biologicals beyond mRNA – including near-term commercial products to support facility viability. 'We have successfully progressed with the technology transfer to eight Partners — a testament to the strength and openness of this platform,' said Prof. Petro Terblanche, CEO of Afrigen Biologics. 'What comes next is even more exciting: Afrigen is on the cusp of receiving GMP accreditation, positioning us not only as a technology originator but as a sustainable manufacturing and innovation partner for the Global South. We will continue to work with local and global partners on the development of new vaccines prioritizing the burden of disease in LMICs.' A diversity of models, one global goal The Programme's Phase 2.0 recognises that there is no one-size-fits-all model. Manufacturers will develop tailored business strategies based on national health needs and policy, regulatory maturity and regional market dynamics. Some, like Bio-Manguinhos and Sinergium in Latin America, BioFarma in Indonesia, and Biovac in South Africa, are already piloting investment roadmaps with detailed market, regulatory, and COGS (cost of goods sold) modelling. Others will receive bespoke support to develop their investment cases. Crucially, sustainability will depend on country and regional-level procurement commitments, pooled purchasing mechanisms, and cross-border alignment — especially in Africa and Asia, where national markets alone may be insufficient to support GMP-level manufacturing scale. 'We need to back science with smart policy,' said Dr Mmboneni Muofhe of South Africa's Department of Science, Technology and Innovation. 'This is about creating a new ecosystem for public health security, grounded in regional ownership, long-term strategy and investments.' Rising demand meets structural barriers While market opportunities for mRNA vaccines and therapeutics are growing — from seasonal influenza and HPV to innovative cancer treatments — the Programme acknowledges structural hurdles: Misinformation and vaccine hesitancy; Shifting donor funding priorities that reduce funding availability; High clinical trial costs; and Need for supportive policies and well-defined procurement pathways. The mRNA Programme highlights both the growing interest in regional R&D consortia focused on target diseases of regional relevance like leishmaniasis and malaria, and the drive to advance next-generation technologies focusing on dose sparing, reduced cost of goods and thermostability. Edwin Reichel Flow Communications +27 114404841 email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
